PSPratha Sah

Pratha Sah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pratha Sah has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction to: Scaling Out a Digital-First Behavioral Health Care Model to Primary Care

    by Soo Jeong Youn, Keke Schuler, Pratha Sah, Brittany Jaso-Yim, Mariesa Pennine, Heather O’dEa, Mara Eyllon, J. Ben Barnes, Lily Murillo, Laura Orth, et al.


  • Scaling out a Digital-First Behavioral Health Care Model to Primary Care

    by Soo Jeong Youn, Keke Schuler, Pratha Sah, Brittany Jaso-Yim, Mariesa Pennine, Heather O’dEa, Mara Eyllon, J. Ben Barnes, Lily Murillo, Laura Orth, et al.

    There is an established supply/demand problem in addressing behavioral health needs. A proposed solution is to have primary care providers respond to patients’ behavioral health challenges directly. The current study describes the adaptation and evaluation process of Precision Behavioral Health (PBH), a digital-first behavioral health care model with provider-referral to an ecosystem of digital interventions. User-centered design strategies used to adapt the PBH program included applying process to system-level behaviors, defining target users and their needs, defining workflows, rapid prototyping cycles, and a complimentary mixed-methods iterative development phase with a pilot trial. Twenty-one primary care providers, 164 medical assistants and check out staff, and 45 nursing staff were trained as part of the pilot. The RE-AIM implementation framework was used for evaluation. Fourteen primary care providers participated in a semi-structured interview to provide feedback on their experience. The adapted PBH program reached 39.54% of primary care patients seen by the pilot providers during the timeframe. Providers offered PBH to 76.63% of the patients reached, and 26.10% accepted the PBH referral. Out of the accepted patients, 78.15% registered, 73.95% activated their digital intervention, and 59.09% showed clinical improvement in outcomes. Nineteen (90.48%) pilot providers adopted PBH and referred a median of 2 patients each week. Medical assistants/check out staff scheduled 5% of digital care navigator appointments and 84.03% of provider follow up appointments. Primary care providers used the program’s clinical decision support tool to aid their discussion and referral process with 95.33% of patients that accepted PBH and selected one of the top 3 recommended tools 95% of the time. Qualitative results identified six broad content categories: Overall PBH referral experience, PBH training, PBH eligibility flag, PBH follow-up appointment workflow, impacts of PBH program on providers, and future modifications. Providers described a positive experience with PBH elements, low burden, positive impact on their jobs, and PBH enhancing treatment options for their patients. Primary care providers identified several adaptations, such as expanding PBH to other types of visits (e.g., sick visits), and optimizing workflow for check-out staff when booking follow-up appointments. Primary care providers are willing and able to successfully refer patients to behavioral health digital interventions with minimal training time for onboarding. Patients referred through primary care demonstrate high acceptance rates, and comparable rates of improvement to those that are referred by licensed behavioral health providers. The results have the potential to impact public health, by increasing behavioral health access for patients without adding burden to providers, and providing healthcare organizations an alternative pathway to address increasing needs without having to increase personnel or introduce major organizational changes.


  • Open Access

    Evaluating the Implementation and Clinical Effectiveness of an Innovative Digital First Care Model for Behavioral Health Using the RE-AIM Framework: Quantitative Evaluation

    by Samuel S Nordberg, Brittany A Jaso-Yim, Pratha Sah, Keke Schuler, Mara Eyllon, Mariesa Pennine, Georgia H Hoyler, J Ben Barnes, Lily Hong Murillo, Heather O'DEa, et al.

    Background: In the United States, innovation is needed to address the increasing need for mental health care services and widen the patient-to-provider ratio. Despite the benefits of digital mental health interventions (DMHIs), they have not been effective in addressing patients’ behavioral health challenges as stand-alone treatments. Objective: This study evaluates the implementation and effectiveness of precision behavioral health (PBH), a digital-first behavioral health care model embedded within routine primary care that refers patients to an ecosystem of evidence-based DMHIs with strategically placed human support. Methods: Patient demographic information, triage visit outcomes, multidimensional patient-reported outcome measure, enrollment, and engagement with the DMHIs were analyzed using data from the electronic health record and vendor-reported data files. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework was used to evaluate the implementation and clinical effectiveness outcomes of PBH. Results: PBH had a 47.58% reach rate, defined as patients accepting the PBH referral from their behavioral health integrated clinician. PBH patients had high DMHI registration rates (79.62%), high activation rates (76.54%), and high retention rates at 15 days (57.69%) and 30 days (44.58%) compared to literature benchmarks. In total, 74.01% (n=168) of patients showed clinical improvement, 22.47% (n=51) showed no clinical change, and 3.52% (n=8) showed clinical deterioration in symptoms. PBH had high adoption rates, with behavioral health integrated clinicians referring on average 4.35 (SD 0.46) patients to PBH per month and 90%-100% of clinicians (n=12) consistently referring at least 1 patient to PBH each month. A third (32%, n=1114) of patients were offered PBH as a treatment option during their triage visit. Conclusions: PBH as a care model with evidence-based DMHIs, human support for patients, and integration within routine settings offers a credible service to support patients with mild to moderate mental health challenges. This type of model has the potential to address real-life access to care problems faced by health care settings.


  • Open Access

    Evaluating the Implementation and Clinical Effectiveness of an Innovative Digital First Care Model for Behavioral Health Using the RE-AIM Framework: Quantitative Evaluation (Preprint)

    by Samuel S Nordberg, Brittany A Jaso-Yim, Pratha Sah, Keke Schuler, Mara Eyllon, Mariesa Pennine, Georgia H Hoyler, J Ben Barnes, Lily Hong Murillo, Heather O'Dea, et al.

    BACKGROUND In the United States, innovation is needed to address the increasing need for mental health care services and widen the patient-to-provider ratio. Despite the benefits of digital mental health interventions (DMHIs), they have not been effective in addressing patients’ behavioral health challenges as stand-alone treatments. OBJECTIVE This study evaluates the implementation and effectiveness of precision behavioral health (PBH), a digital-first behavioral health care model embedded within routine primary care that refers patients to an ecosystem of evidence-based DMHIs with strategically placed human support. METHODS Patient demographic information, triage visit outcomes, multidimensional patient-reported outcome measure, enrollment, and engagement with the DMHIs were analyzed using data from the electronic health record and vendor-reported data files. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework was used to evaluate the implementation and clinical effectiveness outcomes of PBH. RESULTS PBH had a 47.58% reach rate, defined as patients accepting the PBH referral from their behavioral health integrated clinician. PBH patients had high DMHI registration rates (79.62%), high activation rates (76.54%), and high retention rates at 15 days (57.69%) and 30 days (44.58%) compared to literature benchmarks. In total, 74.01% (n=168) of patients showed clinical improvement, 22.47% (n=51) showed no clinical change, and 3.52% (n=8) showed clinical deterioration in symptoms. PBH had high adoption rates, with behavioral health integrated clinicians referring on average 4.35 (SD 0.46) patients to PBH per month and 90%-100% of clinicians (n=12) consistently referring at least 1 patient to PBH each month. A third (32%, n=1114) of patients were offered PBH as a treatment option during their triage visit. CONCLUSIONS PBH as a care model with evidence-based DMHIs, human support for patients, and integration within routine settings offers a credible service to support patients with mild to moderate mental health challenges. This type of model has the potential to address real-life access to care problems faced by health care settings. CLINICALTRIAL

  • Leveraging Implementation Science to Integrate Digital Mental Health Interventions as part of Routine Care in a Practice Research Network

    by Soo Jeong Youn, Brittany Jaso, Mara Eyllon, Pratha Sah, Georgia Hoyler, John Ben Barnes, Kevin Jarama, Lily Murillo, Heather O’dEa, Laura Orth, et al.

    The supply / demand issue in behavioral health care is a well-established fact, and the mental health toll of the COVID-19 pandemic continues to add challenges to an already taxed system. Existing healthcare models are not set up to adequately address the increasing mental health related needs. As such, innovative models are needed to provide patients with access to appropriate, evidence-based behavioral health care within routine clinical care. This paper introduces Precision Behavioral Health (PBH) as an example of such a model. PBH is an innovative, digital first care delivery model that provides an ecosystem of evidence-based digital mental health interventions to patients as a frontline behavioral health treatment within routine care in a large multispecialty group medical center in the United States. This paper describes the implementation of PBH within a practice research network set-up as part of an integrated behavioral health department. We will present how our team leveraged the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance; “What is RE-AIM?,“ n.d.) implementation science framework, which emphasizes the design, dissemination, and implementation processes at the individual, staff, and organizational levels, to prioritize key implementation constructs to enhance the successful integration of PBH within routine care. We describe how each of these constructs were operationalized to aid data gathering for rapid evaluation and lessons learned. We discuss the benefits of these types of initiatives across multiple stakeholders including patients, providers, organizations, payers, and digital intervention vendors.


  • Open Access

    Disease burden among Ukrainians forcibly displaced by the 2022 Russian invasion

    by Abhishek Pandey, Chad R. Wells, Valentyn Stadnytskyi, Seyed M. Moghadas, Madhav V. Marathe, Pratha Sah, William Crystal, Lauren Ancel Meyers, Burton H. Singer, Olena Nesterova, et al.

    The Russian invasion of Ukraine on February 24, 2022, has displaced more than a quarter of the population. Assessing disease burdens among displaced people is instrumental in informing global public health and humanitarian aid efforts. We estimated the disease burden in Ukrainians displaced both within Ukraine and to other countries by combining a spatiotemporal model of forcible displacement with age- and gender-specific estimates of cardiovascular disease (CVD), diabetes, cancer, HIV, and tuberculosis (TB) in each of Ukraine’s 629 raions (i.e., districts). Among displaced Ukrainians as of May 13, we estimated that more than 2.63 million have CVDs, at least 615,000 have diabetes, and over 98,500 have cancer. In addition, more than 86,000 forcibly displaced individuals are living with HIV, and approximately 13,500 have TB. We estimated that the disease prevalence among refugees was lower than the national disease prevalence before the invasion. Accounting for internal displacement and healthcare facilities impacted by the conflict, we estimated that the number of people per hospital has increased by more than two-fold in some areas. As regional healthcare systems come under increasing strain, these estimates can inform the allocation of critical resources under shifting disease burdens.


  • Open Access

    The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2

    by Jeffrey P. Townsend, Hayley B. Hassler, Pratha Sah, Alison P. Galvani, Alex Dornburg

    The durability of vaccine-mediated immunity to SARS-CoV-2, the durations to breakthrough infection, and the optimal timings of booster vaccination are crucial knowledge for pandemic response. Here, we applied comparative evolutionary analyses to estimate the durability of immunity and the likelihood of breakthrough infections over time following vaccination by BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), ChAdOx1 (Oxford-AstraZeneca), and Ad26.COV2.S (Johnson & Johnson/Janssen). We evaluated anti-Spike (S) immunoglobulin G (IgG) antibody levels elicited by each vaccine relative to natural infection. We estimated typical trajectories of waning and corresponding infection probabilities, providing the distribution of times to breakthrough infection for each vaccine under endemic conditions. Peak antibody levels elicited by messenger RNA (mRNA) vaccines mRNA-1273 and BNT1262b2 exceeded that of natural infection and are expected to typically yield more durable protection against breakthrough infections (median 29.6 mo; 5 to 95% quantiles 10.9 mo to 7.9 y) than natural infection (median 21.5 mo; 5 to 95% quantiles 3.5 mo to 7.1 y). Relative to mRNA-1273 and BNT1262b2, viral vector vaccines ChAdOx1 and Ad26.COV2.S exhibit similar peak anti-S IgG antibody responses to that from natural infection and are projected to yield lower, shorter-term protection against breakthrough infection (median 22.4 mo and 5 to 95% quantiles 4.3 mo to 7.2 y; and median 20.5 mo and 5 to 95% quantiles 2.6 mo to 7.0 y; respectively). These results leverage the tools from evolutionary biology to provide a quantitative basis for otherwise unknown parameters that are fundamental to public health policy decision-making.


  • Open Access

    Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic

    by Alison P. Galvani, Alyssa S. Parpia, Abhishek Pandey, Pratha Sah, Kenneth Colón, Gerald Friedman, Travis Campbell, James G. Kahn, Burton H. Singer, Meagan C. Fitzpatrick

    The fragmented and inefficient healthcare system in the United States leads to many preventable deaths and unnecessary costs every year. During a pandemic, the lives saved and economic benefits of a single-payer universal healthcare system relative to the status quo would be even greater. For Americans who are uninsured and underinsured, financial barriers to COVID-19 care delayed diagnosis and exacerbated transmission. Concurrently, deaths beyond COVID-19 accrued from the background rate of uninsurance. Universal healthcare would alleviate the mortality caused by the confluence of these factors. To evaluate the repercussions of incomplete insurance coverage in 2020, we calculated the elevated mortality attributable to the loss of employer-sponsored insurance and to background rates of uninsurance, summing with the increased COVID-19 mortality due to low insurance coverage. Incorporating the demography of the uninsured with age-specific COVID-19 and nonpandemic mortality, we estimated that a single-payer universal healthcare system would have saved about 212,000 lives in 2020 alone. We also calculated that US$105.6 billion of medical expenses associated with COVID-19 hospitalization could have been averted by a single-payer universal healthcare system over the course of the pandemic. These economic benefits are in addition to US$438 billion expected to be saved by single-payer universal healthcare during a nonpandemic year.


  • Open Access

    Projecting the seasonality of endemic COVID-19

    by Jeffrey P. Townsend, April D. Lamb, Hayley B. Hassler, Pratha Sah, Aia Alvarez Nishio, Cameron Nguyen, Alexandra D. Tew, Alison P. Galvani, Alex Dornburg

    Successive waves of infection by SARS-CoV-2 have left little doubt that this virus will transition to an endemic disease 1,2. Projections of the endemic seasonality of SARS-CoV-2 transmission are crucial to informed public health policy 3. Such projections are not only essential to well-timed interventions and the preparation of healthcare systems for synchronous surges with other respiratory viruses 4, but also to the elimination of seasonality as a confounder in the identification of surges that are occurring due to viral evolution, changes in host immunity, or other non-seasonal factors. However, the less than two-year duration of SARS-CoV-2 circulation, pandemic dynamics, and heterogeneous implementation of interventions have grievously complicated evaluations of its seasonality 5. Here we estimate the impending endemic seasonality of SARS-CoV-2 in global population centers via a novel phylogenetic ancestral and descendent states approach 6 that leverages long-term data on the incidence of circulating coronaviruses. Our results validate a major concern that endemic COVID-19 will typically surge coincident with other high-morbidity and -mortality respiratory virus infections such as influenza and RSV 7. In temperate locales in the Northern Hemisphere, we identify spatiotemporal surges of incidences that range from October through January in New York to January through March in Yamagata, Japan. This knowledge of likely spatiotemporal surges of COVID-19 is fundamental to optimal timing of public health interventions that anticipate the impending endemicity of this disease and mitigate SARS-CoV-2 transmission.


  • Open Access

    Impact of accelerating booster vaccination amidst Omicron surge in the United States

    by Pratha Sah, Thomas Nogueira Vilches, Seyed M. Moghadas, Meagan C. Fitzpatrick, Eric C Schneider, Alison P. Galvani

    COVID-19 infections driven by the Omicron variant are sweeping across the United States. Although early evidence suggests that the Omicron variant may cause less severe disease than previous variants, the explosive spread of infections threatens to drive hospitalizations and deaths to unprecedented high levels, swamping already overburdened hospitals. Booster vaccination appears to be effective at preventing severe illness and hospitalization. However, the pace of booster vaccination in the US has been slow despite the available infrastructure to administer doses at a much higher rate. We used an age-stratified, multi-variant agent-based model to project the reduction in COVID-related deaths and hospitalizations that could be achieved by accelerating the current daily pace of booster vaccination in the US. We found that doubling the rate of booster vaccination would prevent over 400,000 hospitalizations and 48,000 deaths. Tripling the booster vaccination rate would avert over 600,000 hospitalizations and save 70,000 lives during the first four months of 2022.